Title:
PROSTATE-SPECIFIC MEMBRANE ANTIGEN-BASED PROSTATE CANCER PATIENT SCREENING METHOD
Document Type and Number:
WIPO Patent Application WO/2019/050149
Kind Code:
A3
Abstract:
According to an embodiment of the present invention, provided is a prostate cancer patient screening method by means of an optical image analysis of a blood circulating cancer cell marker and a prostate-specific membrane antigen.
More Like This:
Inventors:
JEON BYUNG HEE (KR)
Application Number:
PCT/KR2018/008048
Publication Date:
May 02, 2019
Filing Date:
July 17, 2018
Export Citation:
Assignee:
CYTOGEN INC (KR)
International Classes:
G01N33/483; G01N15/00; G01N15/14; G01N21/64; G01N33/574
Foreign References:
US20160011198A1 | 2016-01-14 | |||
KR20170038724A | 2017-04-07 | |||
KR101279918B1 | 2013-07-01 | |||
US20120148142A1 | 2012-06-14 |
Other References:
FRIEDLANDER, T. W. ET AL.: "Detection and Characterization of Invasive Circulating Tumor Cells Derived from Men with Metastatic Castration-resistant Prostate Cancer", INT. J. CANCER, vol. 134, 2014, pages 2284 - 2293, XP055380990, DOI: doi:10.1002/ijc.28561
Attorney, Agent or Firm:
JIDAM IP LAW FIRM et al. (KR)
Download PDF:
Previous Patent: LEAK-DETECTING SENSOR ASSEMBLY
Next Patent: AXL-BASED CANCER PATIENT SCREENING METHOD
Next Patent: AXL-BASED CANCER PATIENT SCREENING METHOD